Transaction Search Form: please type in any of the fields below.
Date: November 22, 2024 Fri
Time: 11:43 am
Time: 11:43 am
Results for drugged driving (u.s.)
2 results foundAuthor: DuPont, Robert L. Title: Drugged Driving Research: A White Paper Summary: Drugged driving is a significant public health and public safety problem in the United States and abroad, as documented through a growing body of research. Among the research conducted in the US is the 2009 finding that 33% of fatally injured drivers with known drug test results were positive for drugs other than alcohol. Among randomly stopped weekend nighttime drivers who provided oral fluid and/or blood specimens in 2007, 16.3% were positive for drugs. While these and other emerging data demonstrate the drugged driving problem, the US has lagged behind other nations in both drugged driving research and enforcement. The White House Office of National Drug Control Policy’s (ONDCP) 2010 National Drug Control Strategy established as a priority reducing drugged driving in the United States. To achieve the Strategy’s goal of reducing drugged driving by 10% by 2015, the National Institute on Drug Abuse (NIDA) enlisted the Institute for Behavior and Health, Inc. (IBH) to review the current state of knowledge about drugged driving and to develop a comprehensive research plan for future research that would hold the promise of making a significant impact by 2015. IBH convened an expert committee to develop this report. Committee members included top leaders across a broad spectrum of related disciplines including research, public policy, enforcement and law. Details: Rockville, MD: Institute for Behavior and Health, Inc., 2011. 62p. Source: Internet Resource: Accessed June 27, 2011 at: http://www.whitehousedrugpolicy.gov/publications/pdf/nida_dd_paper.pdf Year: 2011 Country: United States URL: http://www.whitehousedrugpolicy.gov/publications/pdf/nida_dd_paper.pdf Shelf Number: 121829 Keywords: Driving Under the Influence of DrugsDrug AbuseDrug-Impaired DrivingDrugged Driving (U.S.)Drugs and Driving |
Author: Kay, Gary G. Title: Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving Summary: In November 2008 and again in March 2009, an expert panel was convened by the National Highway Traffic Safety Administration with the goal of determining whether a list could be developed to indicate which medications or classes of medications may pose a hazard to driving. There was particular interest in having the panel develop a list of “safe” medications that do not impair driving. The value of the list would be to better inform patients and physicians regarding the likely effects of a drug on driving. This information could lead to better-informed prescribing practices and to more rational selection of medications by patients. The panel was composed of an international group of behavioral scientists, epidemiologists, pharmacologists, toxicologists, and traffic safety professionals to provide a broad-based perspective on the issue. Discussions included prescription (Rx) medications as well as over-the-counter (OTC) medications and illicit drugs. Although illicit drugs are best known for their impairing effects, Rx and OTC medications are also known to be capable of producing impairment and many are frequently encountered in impaired driver populations. The panel agreed that one of the barriers to categorizing drugs with respect to driving impairment risk is the lack of a common, standardized protocol for assessing the impairing potential of drugs. The panel recognized the need for a structured, standardized protocol for assessing the driving impairment risk of drugs that would lead to better classification of drugs in terms of driving impairment risk. The approach could be useful in providing more meaningful precautions for users and prescribers regarding the impact of drugs on driving. This report provides the background for the project and assembly of the expert panel, a description of the proposed protocol, and offers examples of how the protocol could be useful in evaluating a drug. Details: Washington, DC: National Highway Traffic Safety, Administration Office of Behavioral Safety Research, 2011. 28p. Source: Internet Resource: DOT HS 811 438: Accessed November 24, 2012 at: www.nhtsa.gov/staticfiles/nti/pdf/811438.pdf Year: 2011 Country: United States URL: Shelf Number: 126993 Keywords: Driving Under the InfluenceDrugged Driving (U.S.)Drugs and DrivingPrescription Drugs |